New drug tested to keep aggressive lymphoma at bay after transplant

NCT ID NCT01908777

Summary

This study tested whether adding a drug called romidepsin after a stem cell transplant could help patients with T cell lymphoma stay in remission longer. The trial involved 47 patients who had already achieved a partial or complete response to initial chemotherapy. Researchers followed patients for two years to see if the maintenance therapy improved survival without the cancer progressing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for T CELL NON-HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fred Hutchinson Cancer Research Center (Data Collection Only)

    Seattle, Washington, 98109, United States

  • Memorial Sloan Kettering Cancer Center

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 11065, United States

  • Memorial Sloan Kettering Cancer Center @ Suffolk

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester

    Harrison, New York, 10604, United States

  • Moffitt Cancer Center

    Tampa, Florida, 33612, United States

  • University of Washington (Data Collection Only)

    Seattle, Washington, 98109, United States

  • Weill Cornell Medical Center

    New York, New York, United States

Conditions

Explore the condition pages connected to this study.